Gilead Sciences, Inc. (GILD) financial statements (2021 and earlier)

Company profile

Business Address 333 LAKESIDE DR
FOSTER CITY, CA 94404
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7,40824,35230,08925,51011,89514,60710,128
Cash and cash equivalents5,99711,63117,9407,5888,22912,85110,027
Short-term investments1,41112,72112,14917,9223,6661,756101
Receivables4,9013,5823,3273,8514,5145,8544,635
Inventory, net of allowances, customer advances and progress billings1,6839228148011,5871,9551,386
Inventory1,6839228148011,5871,9551,386
Prepaid expense    231240194
Other current assets    1,062506472
Other undisclosed current assets2,0041,4401,6061,6611,1561,601899
Total current assets:15,99630,29635,83631,82320,44524,76317,714
Noncurrent Assets
Inventory, Noncurrent      489
Property, plant and equipment4,9674,5024,0063,2952,8652,2761,674
Long-term investments and receivables5021,4881,42311,18420,48511,6011,598
Long-term investments5021,4881,42311,18420,48511,6011,598
Intangible assets, net (including goodwill)41,23417,90319,85521,25910,14311,41912,245
Goodwill8,1084,1174,1174,1591,1721,1721,172
Intangible assets, net (excluding goodwill)33,12613,78615,73817,1008,97110,24711,073
Prepaid expense    423400466
Other noncurrent assets5,7087,4382,5552,7222,2141,056731
Other undisclosed noncurrent assets    402324(253)
Total noncurrent assets:52,41131,33127,83938,46036,53227,07616,950
TOTAL ASSETS:68,40761,62763,67570,28356,97751,83934,664
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,1803,7873,9294,1843,9964,7952,828
Accounts payable8447137908141,2061,178955
Accrued liabilities4,3363,0743,1393,3702,7903,1721,452
Employee-related liabilities     380316
Taxes payable     65105
Debt2,7572,4992,7482,747 983483
Deferred revenue and credits 202440134
Other undisclosed current liabilities3,4603,4733,9284,7045,0213,6732,316
Total current liabilities:11,3979,75910,60511,6359,2199,8915,761
Noncurrent Liabilities
Long-term debt and lease obligation28,64522,09424,57430,79526,34621,19511,921
Long-term debt, excluding current maturities28,64522,09424,57430,79526,34621,19511,921
Liabilities, other than long-term debt10,1447,1246,9627,3522,0491,6381,148
Accounts payable and accrued liabilities5,0166,1155,9226,7941,7531,243562
Deferred tax liabilities, net    51
Other liabilities5,1281,0091,040558296395535
Total noncurrent liabilities:38,78929,21831,53638,14728,39522,83313,069
Total liabilities:50,18638,97742,14149,78237,61432,72418,830
Temporary equity, carrying amount     215
Stockholders' equity
Stockholders' equity attributable to parent18,20222,52521,38720,44218,88718,53415,426
Common stock1111112
Additional paid in capital3,8803,0512,2821,2644544442,391
Accumulated other comprehensive income (loss)(60)858016527888301
Retained earnings14,38119,38819,02419,01218,15418,00112,732
Stockholders' equity attributable to noncontrolling interest1912514759476579393
Total stockholders' equity:18,22122,65021,53420,50119,36319,11315,819
TOTAL LIABILITIES AND EQUITY:68,40761,62763,67570,28356,97751,83934,664

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues24,68922,44922,12726,10730,39032,63924,890
Revenue, net26,10730,39032,63924,890
Cost of revenue
(Cost of Goods and Services Sold)
(4,572)(4,675)(4,853)(4,371)(4,261)(4,006)(3,788)
Gross profit:20,11717,77417,27421,73626,12928,63321,102
Operating expenses(16,046)(14,287)(9,894)(7,612)(8,928)(6,440)(5,837)
Other undisclosed operating income 800820 432  
Operating income:4,0714,2878,20014,12417,63322,19315,265
Nonoperating income (expense)(1,418)1,8686765234281543
Investment income, nonoperating(51)22(2)  117136
Foreign currency transaction loss, before tax      (4)
Interest and debt expense(984)(995)(1,077)(1,118)(964)(688)(412)
Income from continuing operations before income taxes:1,6695,1607,79913,52917,09721,65914,856
Income tax expense (benefit)(1,580)204(2,339)(8,885)(3,609)(3,553)(2,797)
Net income:895,3645,4604,64413,48818,10612,059
Net income (loss) attributable to noncontrolling interest3422(5)(16)13242
Net income available to common stockholders, diluted:1235,3865,4554,62813,50118,10812,101

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income:895,3645,4604,64413,48818,10612,059
Other comprehensive income (loss)(145)5208(113)190(213)425
Comprehensive income (loss):(56)5,3695,6684,53113,67817,89312,484
Comprehensive income (loss), net of tax, attributable to noncontrolling interest3422(5)(16)13242
Comprehensive income (loss), net of tax, attributable to parent:(22)5,3915,6634,51513,69117,89512,526

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: